日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Indigenous rights-based approaches to decolonising research methodologies in settler colonial contexts

在殖民定居背景下,以原住民权利为基础的研究方法去殖民化

Anderson, Peter; Diamond, Zane M; Pham, Thu; Baeza Peña, Angela; Tapia, Carla; Blue, Levon; Saward, Melanie; Hurley, Angelina; Pecar, Kate; Kelly, Amanda; Forbes, Owen; Goerke, Veronica; Diamond, Jeane; Cathcart, Abby; Sato, Chizu; Maeda, Koji; Fox, Russell; Howe, Wren D W

Clinical and immune responses to neoadjuvant fulvestrant with or without enzalutamide in ER+/Her2- breast cancer

ER+/Her2-乳腺癌患者接受新辅助氟维司群联合或不联合恩扎卢胺治疗的临床和免疫反应

Elias, Anthony D; Staley, Alyse W; Fornier, Monica; Vidal, Gregory A; Alami, Vida; Sams, Sharon; Spoelstra, Nicole S; Goodspeed, Andrew; Kabos, Peter; Diamond, Jennifer R; Shagisultanova, Elena; Gallagher, Rosa I; Wulfkuhle, Julia D; Petricoin, Emanuel F; Zolman, Kathryn L; McSpadden, Tessa; Jordan, Kimberly R; Slansky, Jill E; Borges, Virginia F; Gao, Dexiang; Richer, Jennifer K

Phase II trial of fulvestrant plus enzalutamide in ER+/HER2- advanced breast cancer

氟维司群联合恩扎卢胺治疗ER+/HER2-晚期乳腺癌的II期临床试验

Elias, Anthony D; Spoelstra, Nicole S; Staley, Alyse W; Sams, Sharon; Crump, Lyndsey S; Vidal, Gregory A; Borges, Virginia F; Kabos, Peter; Diamond, Jennifer R; Shagisultanova, Elena; Afghahi, Anosheh; Mayordomo, Jose; McSpadden, Tessa; Crawford, Gloria; D'Alessandro, Angelo; Zolman, Kathryn L; van Bokhoven, Adrie; Zhuang, Yonghua; Gallagher, Rosa I; Wulfkuhle, Julia D; Petricoin Iii, Emanuel F; Gao, Dexiang; Richer, Jennifer K

Docking for molecules that bind in a symmetric stack with SymDOCK

使用 SymDOCK 对以对称堆叠方式结合的分子进行对接

Smith, Matthew S; Knight, Ian S; Kormos, Rian C; Pepe, Joseph G; Kunach, Peter; Diamond, Marc I; Shahmoradian, Sarah H; Irwin, John J; DeGrado, William F; Shoichet, Brian K

Clinical Outcomes for Patients With Metastatic Breast Cancer Treated With Immunotherapy Agents in Phase I Clinical Trials

I期临床试验中接受免疫疗法治疗的转移性乳腺癌患者的临床结果

Schreiber, Anna R; Kagihara, Jodi A; Weiss, Jennifer A; Nicklawsky, Andrew; Gao, Dexiang; Borges, Virginia F; Kabos, Peter; Diamond, Jennifer R

HIF-2α Promotes Dissemination of Plasma Cells in Multiple Myeloma by Regulating CXCL12/CXCR4 and CCR1

HIF-2α通过调节CXCL12/CXCR4和CCR1促进多发性骨髓瘤中浆细胞的播散

Kate Vandyke, Mara N Zeissig, Duncan R Hewett, Sally K Martin, Krzysztof M Mrozik, Chee Man Cheong, Peter Diamond, L Bik To, Stan Gronthos, Daniel J Peet, Peter I Croucher, Andrew C W Zannettino

Anticancer efficacy of Apo2L/TRAIL is retained in the presence of high and biologically active concentrations of osteoprotegerin in vivo

在体内存在高浓度且具有生物活性的骨保护素的情况下,Apo2L/TRAIL 的抗癌功效得以保留

Irene Zinonos, Agatha Labrinidis, Michelle Lee, Vasilios Liapis, Shelley Hay, Vladimir Ponomarev, Peter Diamond, David M Findlay, Andrew C W Zannettino, Andreas Evdokiou

Myeloma-induced alloreactive T cells arising in myeloma-infiltrated bones include double-positive CD8+CD4+ T cells: evidence from myeloma-bearing mouse model

骨髓瘤诱导的同种反应性 T 细胞出现在骨髓瘤浸润的骨骼中,包括双阳性 CD8+CD4+ T 细胞:来自骨髓瘤小鼠模型的证据

Lisa M Freeman, Alfred Lam, Eugene Petcu, Robert Smith, Ali Salajegheh, Peter Diamond, Andrew Zannettino, Andreas Evdokiou, John Luff, Pooi-Fong Wong, Dalia Khalil, Nigel Waterhouse, Frank Vari, Alison M Rice, Laurence Catley, Derek N J Hart, Slavica Vuckovic

Hypoxia-inducible factor-2 is a novel regulator of aberrant CXCL12 expression in multiple myeloma plasma cells

缺氧诱导因子 2 是多发性骨髓瘤浆细胞中 CXCL12 异常表达的新型调节剂

Sally K Martin, Peter Diamond, Sharon A Williams, Luen Bik To, Daniel J Peet, Nobutaka Fujii, Stan Gronthos, Adrian L Harris, Andrew C W Zannettino

Apo2L/TRAIL inhibits tumor growth and bone destruction in a murine model of multiple myeloma

Apo2L/TRAIL 抑制小鼠多发性骨髓瘤模型中的肿瘤生长和骨质破坏

Agatha Labrinidis, Peter Diamond, Sally Martin, Shelley Hay, Vasilios Liapis, Irene Zinonos, Natalie A Sims, Gerald J Atkins, Cristina Vincent, Vladimir Ponomarev, David M Findlay, Andrew C W Zannettino, Andreas Evdokiou